Clinical Trial Update: Preliminary Investigation of β-hydroxybutyrate Supplementation in Colorectal Cancer Prevention [NA]

View source ↗

Summary

Preliminary investigation assessing beta-hydroxybutyrate supplementation for colorectal cancer prevention; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• beta-hydroxybutyrate (beta-hydroxybutyrate)

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Colorectal Cancer | NA | Status: ACTIVE_NOT_RECRUITING